CDEK
← All organizations

Cara Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: CARA THERAP | Cara Therapeutics | Cara Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2009

First marketed drug

Aug 23, 2021

First NDA

Aug 23, 2021

Last known activity

Aug 1, 2023

Timeline

2000s

  1. Jul 2, 2004

    Cara Therapeutics— Founded

2020s

  1. Aug 23, 2021

    difelikefalin— Marketing Organization

  2. Aug 23, 2021

    difelikefalin— NDA Organization

  3. Aug 23, 2021

    difelikefalin— NDA Secondary Org

Drugs by trial phase (2 distinct, 24 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (45)

Details

Founded
Shelton, CT, US Jul 2, 2004
First NDA
Aug 23, 2021
Last known activity
Aug 1, 2023

Designations held

  • Priority review
  • Breakthrough therapy